Helen Hrdy's most recent trade in National Research Corp was a trade of 12,346 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| National Research Corp | Helen Hrdy | EVP & Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 12,346 | 0 | - | - | Employee Stock Option (right to buy) | |
| National Research Corp | Helen Hrdy | EVP & Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.23 per share. | 15 Dec 2025 | 12,346 | 151,762 (0%) | 0% | 15.2 | 188,030 | Common Stock |
| National Research Corp | Helen Hrdy | EVP & Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.64 per share. | 15 Dec 2025 | 11,244 | 140,518 (0%) | 0% | 17.6 | 198,344 | Common Stock |
| National Research Corp | Helen Hrdy | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2025 | 100,000 | 139,416 (0%) | 0% | 0 | Common Stock | |
| National Research Corp | Helen Hrdy | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 10,981 | 10,981 | - | - | Employee Stock Option (right to buy) | |
| National Research Corp | Helen Hrdy | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 10,118 | 10,118 | - | - | Employee Stock Option (right to buy) | |
| National Research Corp | Helen Hrdy | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. | 28 Dec 2021 | 13,520 | 46,345 (0%) | 0% | 13.2 | 178,058 | Common Stock |
| National Research Corp | Helen Hrdy | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 13,520 | 0 | - | - | Employee Stock Option (right to buy) | |
| National Research Corp | Helen Hrdy | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.50 per share. | 28 Dec 2021 | 6,929 | 39,416 (0%) | 0% | 42.5 | 294,483 | Common Stock |